» Articles » PMID: 29803552

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction

Overview
Journal JACC Heart Fail
Publisher Elsevier
Date 2018 May 28
PMID 29803552
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD).

Background: Peak Vo is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo and its role in the clinical evaluation of HFpEF are unclear.

Methods: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD.

Results: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo in HFpEF, even after accounting for known determinants of O transport according to the Fick principle. Very low upright peak Vo (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo cutoff points were associated with substantial overlap between cases and NCD.

Conclusions: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo.

Citing Articles

Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with non-reduced ejection fraction.

Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.

PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.


Cardiorenal Disease and Heart Failure with Preserved Ejection Fraction: Two Sides of the Same Coin.

Nunez-Marina G, Nunez-Marin G, Santas E Cardiorenal Med. 2025; 15(1):108-121.

PMID: 39778558 PMC: 11844673. DOI: 10.1159/000543390.


Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.

Berger J, Shi Y, Matsuura T, Batmanov K, Chen X, Tam K Sci Rep. 2025; 15(1):422.

PMID: 39747575 PMC: 11696687. DOI: 10.1038/s41598-024-84515-9.


Advancing Cardiac Amyloidosis Care Through Insights from Cardiopulmonary Exercise Testing.

Pugliatti P, Trimarchi G, Barocelli F, Pizzino F, Di Spigno F, Tedeschi A J Clin Med. 2024; 13(23).

PMID: 39685743 PMC: 11642058. DOI: 10.3390/jcm13237285.


Aerobic Capacity of Adults With Fontan Palliation: Disease-Specific Reference Values and Relationship to Outcomes.

Egbe A, Ali A, Miranda W, Connolly H, Borlaug B Circ Heart Fail. 2024; 18(2):e011981.

PMID: 39648896 PMC: 11835545. DOI: 10.1161/CIRCHEARTFAILURE.124.011981.


References
1.
Haykowsky M, Brubaker P, John J, Stewart K, Morgan T, Kitzman D . Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011; 58(3):265-74. PMC: 3272542. DOI: 10.1016/j.jacc.2011.02.055. View

2.
Reddy Y, Lewis G, Shah S, LeWinter M, Semigran M, Davila-Roman V . INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Circ Heart Fail. 2017; 10(5). PMC: 5484533. DOI: 10.1161/CIRCHEARTFAILURE.117.003862. View

3.
Dhakal B, Malhotra R, Murphy R, Pappagianopoulos P, Baggish A, Weiner R . Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail. 2014; 8(2):286-94. PMC: 5771713. DOI: 10.1161/CIRCHEARTFAILURE.114.001825. View

4.
Borlaug B, Carter R, Melenovsky V, DeSimone C, Gaba P, Killu A . Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2017; 10(4):e003612. PMC: 5390814. DOI: 10.1161/CIRCHEARTFAILURE.116.003612. View

5.
Maron B, Cockrill B, Waxman A, Systrom D . The invasive cardiopulmonary exercise test. Circulation. 2013; 127(10):1157-64. DOI: 10.1161/CIRCULATIONAHA.112.104463. View